Zendehrokh N

No ORCID on file · 1 paper in corpus
observational 2013
Diagnostic pathology ·doi:10.1186/1746-1596-8-106

BACKGROUND: Activating KRAS mutations are common in ovarian carcinomas of low histological grade, less advanced clinical stage and mucinous histological subtype, and form part of the distinct molecular alterations associated with type I tum…